000 01512 a2200433 4500
005 20250515080540.0
264 0 _c20080215
008 200802s 0 0 eng d
022 _a0012-186X
024 7 _a10.1007/s00125-007-0785-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDing, E L
245 0 0 _aPlasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study.
_h[electronic resource]
260 _bDiabetologia
_cOct 2007
300 _a2076-84 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAspirin
_xtherapeutic use
650 0 4 _aBody Mass Index
650 0 4 _aCardiovascular Diseases
_xprevention & control
650 0 4 _aDehydroepiandrosterone Sulfate
_xblood
650 0 4 _aDiabetes Mellitus, Type 2
_xepidemiology
650 0 4 _aDouble-Blind Method
650 0 4 _aEstradiol
_xblood
650 0 4 _aFemale
650 0 4 _aGlycated Hemoglobin
_xanalysis
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aPostmenopause
650 0 4 _aRisk Factors
650 0 4 _aTestosterone
_xblood
650 0 4 _aVitamin E
_xtherapeutic use
700 1 _aSong, Y
700 1 _aManson, J E
700 1 _aRifai, N
700 1 _aBuring, J E
700 1 _aLiu, S
773 0 _tDiabetologia
_gvol. 50
_gno. 10
_gp. 2076-84
856 4 0 _uhttps://doi.org/10.1007/s00125-007-0785-y
_zAvailable from publisher's website
999 _c17232437
_d17232437